2nd Annual UT Southwestern Gastrointestinal Cancer Symposium

Saturday, April 21, 2012

GI cancer symposium
Location

UT Southwestern Medical Center
T. Boone Pickens
Biomedical Building Auditorium
6001 Forest Park Road
Dallas, Texas 75390

Target Audience

Physicians, NPs, RNs and PAs interested in the treatment of GI cancer within the fields of family practice, internal medicine, gastroenterology, advanced endoscopy, medical oncology, diagnostic radiology, interventional radiology, general surgery, surgical oncology, and transplantation medicine.

Program Overview

This one-day course on multidisciplinary aspects of gastrointestinal cancer is organized to offer concise reviews, the latest management updates and clinical protocol opportunities to physicians participating in the diagnosis and treatment of gastrointestinal cancer. It also features a tumor board discussion of challenging cases that highlights the process of organizing multiple specialties involved in therapeutic delivery.

Educational Objectives

Upon completion of this symposium, the participants should be able to link the educational objectives to Core Competencies (Medical Knowledge and Patient Care) and be able to describe and discuss:

  • Differentiate indications and outcomes after curative HCC treatment options in form of transplantation and resection
  • Review noncurative local and regional HCC therapies, including various embolization and ablation techniques
  • Assess current standard and experimental systemic therapy options for HCC
  • Explain operative resection and indications for perioperative multidisciplinary therapy for pancreatic cancer
  • Summarize improvements in the systemic treatment for advanced
    pancreatic cancer
  • Apply multimodality therapy to rectal cancer
  • Review surgical approaches to optimize sphincter preservation and regional control with robotic technology
  • Review developments in systemic therapies for colorectal cancer
  • Design multimodality strategies to optimize cure rates for metastatic colorectal cancer
  • Review a program for management of recurrent rectal cancer and intrapelvic malignancies
  • Identify diagnostic and therapeutic steps for gastroesophageal cancer
  • Select approaches for multimodality therapy of gastroesophageal cancers
  • Select options for minimal invasive therapy for localized GI cancers
  • Review indications for adjuvant and definitive systemic therapy for GIST
  • Select between locoregional and systemic options for treatment of advanced neuroendocrine tumors
  • Choose indications for intraperitoneal therapy options for patients with peritoneal carcinomatosis

Accreditation

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The University of Texas Southwestern Medical Center designates this educational activity for a maximumof 5.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Conflict of Interest

It is UT Southwestern’s policy that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Each speaker has completed and signed a conflict of interest statement. The faculty members’ relationships will be disclosed in the course syllabus.

Discussion of Off-Label Use

Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be “off-label” use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed.